Adults 18 to 60, female only, with Human Immunodeficiency Virus. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Knowledge and Experiences of Breastfeeding Among Women Living With HIVPrimary· At their pre-or postnatal outpatient appointment, an average of one day
Participants were recruited by clinicians from 12 HIV clinics across England (South East, West Midlands and West Yorkshire) between June 2017 and June 2018. Participants were given the study patient information leaflet and consent form when they attended their regular pre- or postnatal outpatient appointment and, if they agreed to participate, they completed the anonymised questionnaire (Supplemental Appendix X) during the same visit. All the questionnaires were collated at Imperial College Healthcare NHS Trust.
In the data table, breastfeeding has been abbreviated to BF.
Have any friends, family or community members questioned you about your reasons for not BF?
Group
Value
95% CI
Women Living With HIV
58
Women Living With HIV
25
Women Living With HIV
0
Women Living With HIV
11
Have you ever had to lie about your reasons for not BF?
Group
Value
95% CI
Women Living With HIV
62
Women Living With HIV
21
Women Living With HIV
0
Women Living With HIV
11
If you did not have HIV, would you BF your child?
Group
Value
95% CI
Women Living With HIV
84
Women Living With HIV
2
Women Living With HIV
8
Women Living With HIV
0
Living with HIV, would you like to BF your child?
Group
Value
95% CI
Women Living With HIV
36
Women Living With HIV
45
Women Living With HIV
6
Women Living With HIV
7
Do you think it's safe for women with detectable HIV in the blood to BF?
Group
Value
95% CI
Women Living With HIV
3
Women Living With HIV
63
Women Living With HIV
22
Women Living With HIV
6
Do you think it's safe for women on treatment with fully suppressed HIV to BF?
Group
Value
95% CI
Women Living With HIV
26
Women Living With HIV
33
Women Living With HIV
31
Women Living With HIV
4
If you were to BF, would you have monthly blood tests to check your viral load stays undetectable?
Group
Value
95% CI
Women Living With HIV
83
Women Living With HIV
10
Women Living With HIV
0
Women Living With HIV
1
If you were to BF, would you be willing for your baby to have a monthly HIV blood test?
Group
Value
95% CI
Women Living With HIV
79
Women Living With HIV
13
Women Living With HIV
0
Women Living With HIV
2
Views on Infant Feeding for Women Living With HIVPrimary· At their pre-or postnatal outpatient appointment, an average of one day
The PACIFY study (Positive Attitudes Concerning Infant Feeding) sought to explore the views, concerns and issues surrounding breastfeeding in women living with HIV (WLHs).
Questions within the questionnaire:
1. If you did not have HIV, would you breastfeed your child?
2. Living with HIV, would you like to breastfeed your child?
would like to breastfeed if they were HIV negative
Group
Value
95% CI
Women Living With HIV
89
would like to breastfeed while living with HIV
Group
Value
95% CI
Women Living With HIV
38
Sponsor's own description
The PACIFY Study is a questionnaire for antenatal(third trimester) and postnatal(three months post delivery) Human Immunodeficiency Virus (HIV) positive women attending clinics in London and Brighton. The current World Health Organisation guidance advises HIV positive women, who are adhering to antiretroviral therapy (ART), to exclusively breastfeed for the first 6 months of the infant's life and continue supplemental breastfeeding for up to 2 years.
This is conflicts with the current British HIV Association guidelines which advise exclusive formula feeding. The reason for this difference is the relative safety of formula feeding in the United Kingdom(UK)against the low but persisting risk of HIV infection through breast-feeding. The aim of the PACIFY study is to explore attitudes towards breastfeeding amongst HIV positive women, who are either pregnant or post-partum. The study will also assess the understanding of current infant feeding guidance by these women and assess their current or recent infant feeding practice. It will also look at whether HIV positive mothers would be willing and able to comply with special monitoring and guidance whilst breastfeeding if the guidelines were to change. The study aims to analyse 100 questionnaires completed over a 3-6 month period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT04466371 — Perceptions of Undergraduate Students and Teaching Staff on Online Teaching
· suspended
NCT07089953 — Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits: a Randomiz
· NA
· not yet recruiting
NCT07418775 — Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
· not yet recruiting
NCT07226804 — Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules
· not yet recruiting
NCT07532954 — The Impact Of A Patient Support Community On Patients With Neuroendocrine Cervical Cancer: NECC Peer Support
· recruiting
Other recruiting trials for Human Immunodeficiency Virus
Currently open trials in the same condition.
NCT07530198 — HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong
· Phase 1
· recruiting
NCT06819176 — Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretrovir
· Phase 1
· recruiting
NCT06408142 — Universal Test and Connect for HIV Service Delivery in South Africa
· recruiting
NCT07101458 — The Eswatini PRISM Study on Adolescents Living With HIV
· NA
· recruiting
NCT06554223 — The SUSTAIN 2 Study - SUStained HIV Treatment for Adherence After Interruption in Care
· NA
· recruiting
Other Imperial College London trials
Trials by the same sponsor.
NCT06035861 — Endothelial Cell Activation and Total Pulmonary Resistance in PAH
· NA
· not yet recruiting
NCT07397455 — Development of a Controlled Human Infection Model for Assessment of SARS-CoV-2 Omicron Subvariants
· Phase 1
· not yet recruiting
NCT07422532 — A Multi-centre Trial to Assess the Efficacy and Safety of the Omnipod 5 System in People With Type 2 Diabetes Undergoing
· NA
· not yet recruiting
NCT07389031 — Maralixibat for Intrahepatic Cholestasis of Pregnancy
· Phase 2
· not yet recruiting
NCT07358897 — Gender Affirming Hormone Therapy and Immune Function in Trans Individuals - The GIFT Study
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Imperial College London
Last refreshed: 2 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03294499.